Degenerative Myelopathy Early-Onset Modifier (Pembroke Welsh Corgi)
Early-Onset Degenerative Myelopathy Modifier · SP110 modifier · Pembroke Welsh Corgi DM Modifier · Frühzeitige Degenerative Myelopathie Modifikator · Corgi DM early-onset risk factor
What it is
This genetic modifier, abbreviated as DMRM, is a variation in the SP110 gene that accelerates the onset of Degenerative Myelopathy (DM) in Pembroke Welsh Corgis. DM is a severe, progressive disease of the spinal cord where the protective sheath around the nerves degrades, disrupting the signals between the brain and the body. Dogs carrying this modifier experience this neurological decline much earlier in life than those without it.
How it presents
Owners typically first notice weakness, unsteadiness, or wobbliness in the hind legs, which gradually progresses to dragging the paws and eventual paralysis. With this early-onset modifier, these symptoms often appear around 7 to 9 years of age.
Treatment
There is no cure for this condition, meaning treatment is lifelong and focuses on supportive care, physical therapy, and mobility aids. The estimated lifetime cost for managing this disease ranges from 2,000 to 8,000 EUR.
How it's tested
Affected breeds
Treatment cost
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.